|
1
|
Tillmann T, Vaucher J, Okbay A, Pikhart H,
Peasey A, Kubinova R, Pajak A, Tamosiunas A, Malyutina S, Hartwig
FP, et al: Education and coronary heart disease: Mendelian
randomisation study. BMJ. 358:j35422017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gilani N, Kazemnejad A, Zayeri F, Hadaegh
F, Azizi F and Khalili D: Anthropometric indices as predictors of
coronary heart disease risk: Joint modeling of longitudinal
measurements and time to event. Iran J Public Health. 46:1546–1554.
2017.PubMed/NCBI
|
|
3
|
Chen L, Wei B, Xu L and Wu Y: The
association of inflammatory markers and periodontal indexes with
the risk of coronary heart disease in Chinese patients with type 2
diabetes mellitus. Diabetes Res Clin Pract. 135:37–44. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang HC and Hong JS: Association between
costs and quality of acute myocardial infarction care hospitals
under the Korea National Health Insurance program. Medicine
(Baltimore). 96:e76222017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yavuz B, Kabakci G, Aksoy H, Tulumen E,
Deveci OS, Aytemir K, Tokgozoglu L, Ozkutlu H, Nazli N and Oto A:
Determining the relationship between metabolic syndrome score and
angiographic severity of coronary artery disease. Int J Clin Pract.
62:717–722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Wu X, Li Y, Han X, Hu H, Wang F,
Yu C, Li X, Yang K, Yuan J, et al: Serum bilirubin concentrations
and incident coronary heart disease risk among patients with type 2
diabetes: The Dongfeng-Tongji cohort. Acta Diabetol. 54:257–264.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Farrokhian A, Bahmani F, Taghizadeh M,
Mirhashemi SM, Aarabi MH, Raygan F, Aghadavod E and Asemi Z:
Selenium supplementation affects insulin resistance and serum
hs-CRP in patients with type 2 diabetes and coronary heart disease.
Horm Metab Res. 48:263–268. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ahmad S, Xue Z, Silverman A and Lindsay J:
Complexity of the relation between hemoglobin A1C, diabetes
mellitus, and progression of coronary narrowing in postmenopausal
women. Am J Cardiol. 111:793–799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Koussih L, Shan L, Halayko AJ,
Chen BK and Gounni AS: TNF up-regulates Pentraxin3 expression in
human airway smooth muscle cells via JNK and ERK1/2 MAPK pathways.
Allergy Asthma Clin Immunol. 11:372015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu M, Lu Q, Zhang Y and Tian G: ApoB/apoA1
is an effective predictor of coronary heart disease risk in
overweight and obesity. J Biomed Res. 25:266–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Claesson R, Ekelund M, Ignell C and
Berntorp K: Role of HbA1c in post-partum screening of women with
gestational diabetes mellitus. J Clin Transl Endocrinol. 2:21–25.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
National standards of P.R.C. Diagnostic
Criteria of Coronary Atherosclerotic Heart Disease. Beijing:
Quality Inspection Press of China 1–4; 2010
|
|
13
|
Deckers JG, Schellevis FG and Fleming DM:
WHO diagnostic criteria as a validation tool for the diagnosis of
diabetes mellitus: A study in five European countries. Eur J Gen
Pract. 12:108–113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Kreutzenberg Vigili S, Solini A, Vitolo
E, Boi A, Bacci S, Cocozza S, Nappo R, Rivellese A, Avogaro A and
Baroni MG: Silent coronary heart disease in patients with type 2
diabetes: Application of a screening approach in a follow-up study.
J Diabetes Complications. 31:952–957. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Emdin CA, Klarin D, Natarajan P, Florez
JC, Kathiresan S and Khera AV and Khera AV: CARDIOGRAM Exome
Consortium: Genetic variation at the sulfonylurea receptor, type 2
diabetes, and coronary heart disease. Diabetes. 66:2310–2315. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Naito A, Tanabe N, Jujo T, Shigeta A,
Sugiura T, Sakao S, Ishida K and Tatsumi K: Pentraxin3 in chronic
thromboembolic pulmonary hypertension: A new biomarker for
screening from remitted pulmonary thromboembolism. PLoS One.
9:e1130862014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tarantino U, Feola M, Celi M and Scimeca
M: PTX3: A new mediator of bone metabolism and osteoporosis.
Muscles Ligaments Tendons J. 7:200–201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ohde S, Deshpande GA, Yokomichi H,
Takahashi O, Fukui T and Yamagata Z: HbA1c monitoring interval in
patients on treatment for stable type 2 diabetes. A ten-year
retrospective, open cohort study. Diabetes Res Clin Pract.
135:166–171. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hansel B, Giral P, Gambotti L, Lafourcade
A, Peres G, Filipecki C, Kadouch D, Hartemann A, Oppert JM,
Bruckert E, et al: A fully automated web-based program improves
lifestyle habits and HbA1c in patients with type 2 diabetes and
abdominal obesity: Randomized trial of patient E-coaching
nutritional support (The ANODE Study). J Med Internet Res.
19:e3602017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mousavi SN, Kamali K, Mirbazel M and
Jameshorani M, Mousavi N, Kamali K, Mirbazel M and Jameshorani M:
The best cut-off value for HbA1c as a screening tool in Iranian
women with gestational diabetes mellitus. J Family Reprod Health.
11:37–42. 2017.PubMed/NCBI
|
|
21
|
Jiang J, Zhao L, Lin L, Gui M, Aleteng Q,
Wu B, Wang S, Pan B, Ling Y and Gao X: Postprandial blood glucose
outweighs fasting blood glucose and HbA1c in screening coronary
heart disease. Sci Rep. 7:142122017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Trivedi H, Gray LJ, Seidu S, Davies MJ,
Charpentier G, Lindblad U, Kellner C, Nolan J, Pazderska A, Rutten
G, et al: Self-knowledge of HbA1c in people with type 2 diabetes
mellitus and its association with glycaemic control. Prim Care
Diabetes. 11:414–420. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bays HE, Shah A, Lin J, Sisk CM, Dong Q
and Maccubbin D: Consistency of extended-release niacin/laropiprant
effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio
across patient subgroups. Am J Cardiovasc Drugs. 12:197–206. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng J, Yin Q, Cao J and Zhang B: Obesity
contributes more to increasing ApoB/ApoA1 ratio than
hyperandrogenism in PCOS women aged 20–38 years in China. Exp Ther
Med. 13:1337–1342. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Öhman M, Öhman ML and Wållberg-Jonsson S:
The apoB/apoA1 ratio predicts future cardiovascular events in
patients with rheumatoid arthritis. Scand J Rheumatol. 43:259–264.
2014. View Article : Google Scholar : PubMed/NCBI
|
